Patents by Inventor Robert Frank Wagner

Robert Frank Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TABLET FORMULATIONS COMPRISING VALSARTAN
    Publication number: 20130237574
    Abstract: The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
    Type: Application
    Filed: August 3, 2012
    Publication date: September 12, 2013
    Applicant: NOVARTIS AG
    Inventors: Sabina Maria Ganter, Robert Frank Wagner
  • SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING THE SAME
    Publication number: 20120177733
    Abstract: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
    Type: Application
    Filed: February 23, 2012
    Publication date: July 12, 2012
    Inventors: Yatindra Joshi, Robert Frank Wagner, Madhusudhan Pudipeddi, Gangadhar Sunkara, Ping Li
  • SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD OF MAKING THE SAME
    Publication number: 20120164218
    Abstract: Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
    Type: Application
    Filed: January 3, 2012
    Publication date: June 28, 2012
    Inventors: Yu Cao, Yatindra Joshi, Ping Li, Madhusudhan Pudipeddi, Alan Edward Royce, Robert Frank Wagner, Jiahao Zhu
  • SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAME
    Publication number: 20100303906
    Abstract: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
    Type: Application
    Filed: August 9, 2010
    Publication date: December 2, 2010
    Inventors: Yatindra Joshi, Robert Frank Wagner, Madhusudhan Pudipeddi, Gangadhar Sunkara, Ping Li
  • Pharmaceutical Compositions
    Publication number: 20100267787
    Abstract: Provided are compositions comprising aqueous solutions of valsartan suitable for oral administration, preferably in pediatric and geriatric populations. Methods for making such compositions and methods for their stabilization are provided.
    Type: Application
    Filed: November 10, 2008
    Publication date: October 21, 2010
    Inventors: Gregory Harasymiw, Wayne Talamonti, Robert Frank Wagner, Joseph Lawrence Zielinski
  • TABLET FORMULATIONS COMPRISING VALSARTAN
    Publication number: 20100267789
    Abstract: The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
    Type: Application
    Filed: July 1, 2010
    Publication date: October 21, 2010
    Applicant: NOVARTIS AG
    Inventors: Sabina Maria Ganter, Robert Frank Wagner
  • Pharmaceutical Formulation of Valsartan
    Publication number: 20100222334
    Abstract: The present invention relates to a pharmaceutical composition in a form of suspension for oral administration comprising valsartan or its pharmaceutically acceptable salts and at least one or two or more of the components selected from glycerol or syrup or the mixture thereof, a preservative, a buffer system and a suspending/stabilizing agent. The present invention further relates to the therapeutic uses of the pharmaceutical composition.
    Type: Application
    Filed: October 7, 2008
    Publication date: September 2, 2010
    Inventors: Wayne Talamonti, Robert Frank Wagner, Hong Wen
  • Solid Dosage Forms of Valsartan and Amlo Dipine and Method of Making the Same
    Publication number: 20080171086
    Abstract: Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
    Type: Application
    Filed: August 15, 2006
    Publication date: July 17, 2008
    Inventors: Yatindra Joshi, Robert Frank Wagner, Madhusudhan Pudipeddi, Gangadhar Sunkara, Ping Li
  • Solid oral dosage forms of valsartan
    Patent number: 6858228
    Abstract: The present invention is concerned with solid oral dosage forms of comprising a) an active agent selected from valsartan and optionally HCTZ, and b) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: February 22, 2005
    Assignee: Novartis AG
    Inventors: Yoshimitsu Katakuse, Manfred Kohlmeyer, Takashi Taike, Robert Frank Wagner, Fujiki Yamato
  • Tablet formulations comprising valsartan
    Publication number: 20030152620
    Abstract: The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
    Type: Application
    Filed: February 25, 2003
    Publication date: August 14, 2003
    Inventors: Sabina Maria Ganter, Robert Frank Wagner
  • Solid oral dosage forms of valsartan
    Patent number: 6485745
    Abstract: The present invention is concerned with solid oral dosage forms of comprising a) an active agent selected from valsartan and optionally HCTZ , and b) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
    Type: Grant
    Filed: August 1, 2001
    Date of Patent: November 26, 2002
    Assignee: Novartis AG
    Inventors: Robert Frank Wagner, Yoshimitsu Katakuse, Takashi Taike, Fujiki Yamato, Manfred Kohlmeyer
  • Tablet formulations comprising valsartan
    Publication number: 20020132839
    Abstract: The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
    Type: Application
    Filed: June 22, 2001
    Publication date: September 19, 2002
    Inventors: Sabina Maria Ganter, Robert Frank Wagner
  • Solid oral dosage forms of valsartan
    Patent number: 6294197
    Abstract: The present invention is concerned with solid dosage forms comprising a) valsartan and optionally HCTZ, and b) pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: September 25, 2001
    Assignee: Novartis AG
    Inventors: Robert Frank Wagner, Yoshimitsu Katakuse, Takashi Taike, Fujiki Yamato, Manfred Kohlmeyer